{"id":24814,"date":"2025-04-13T17:43:14","date_gmt":"2025-04-13T17:43:14","guid":{"rendered":"https:\/\/researchchemicalstore.eu\/?post_type=product&p=24814"},"modified":"2025-10-21T10:29:50","modified_gmt":"2025-10-21T10:29:50","slug":"3d-mxe-40mg-pellets","status":"publish","type":"product","link":"https:\/\/researchchemicalstore.eu\/is\/vara\/3d-mxe-40mg-pellets\/","title":{"rendered":"3D-MXE 40 mg k\u00falur"},"content":{"rendered":"

3D-MXE 40 mg k\u00falur \u2013 N\u00fdst\u00e1rlegt ranns\u00f3knarefni fyrir v\u00edsindalegar ranns\u00f3knir<\/span><\/span><\/strong><\/h1>\n

3D mxe<\/span><\/span><\/p>\n

Um 3D-MXE<\/span><\/span><\/strong><\/h3>\n

3D-MXE er ranns\u00f3knarefni af flokki sundrandi ar\u00fdls\u00fdkl\u00f3hex\u00fdlam\u00edns, byggingarlega svipa\u00f0 MXE (metoxetam\u00edni). \u00deetta efni er eing\u00f6ngu \u00e6tla\u00f0 til h\u00e1\u00fer\u00f3a\u00f0ra lyfjafr\u00e6\u00f0ilegra og taugav\u00edsindaranns\u00f3kna \u00ed st\u00fdr\u00f0um ranns\u00f3knarstofum.<\/span><\/span><\/p>\n

Helstu atri\u00f0i v\u00f6runnar<\/span><\/span><\/strong><\/h3>\n

\u2714\u00a0N\u00e1kv\u00e6m sk\u00f6mmtun<\/span><\/span><\/strong> \u00a0\u2013 40 mg \u00ed hverju k\u00falu fyrir endurtakanlegar ranns\u00f3knarni\u00f0urst\u00f6\u00f0ur <\/span><\/span>
\n\u2714\u00a0\u00cdtarleg form\u00fala<\/span><\/span><\/strong> \u00a0\u2013 Besta l\u00edffr\u00e6\u00f0ilega a\u00f0gengileiki fyrir in vitro ranns\u00f3knir <\/span><\/span>
\n\u2714\u00a0St\u00f6\u00f0ug samsetning<\/span><\/span><\/strong> \u00a0\u2013 Langt\u00edma geymslu\u00feol vi\u00f0 vi\u00f0eigandi a\u00f0st\u00e6\u00f0ur <\/span><\/span>
\n\u2714\u00a0G\u00e6\u00f0avotta\u00f0<\/span><\/span><\/strong> \u00a0\u2013 Sk\u00fdrsla um HPLC pr\u00f3fun er tilt\u00e6k (hreinleiki >97%)<\/span><\/span><\/p>\n

M\u00f6guleg ranns\u00f3knarsvi\u00f0<\/span><\/span><\/strong><\/h3>\n

\u2022 Ranns\u00f3knir \u00e1 NMDA vi\u00f0takablokkun <\/span><\/span>
\n\u2022 Ranns\u00f3knir \u00e1 taugaverndarferlum <\/span><\/span>
\n\u2022 Greining \u00e1 sundrunar\u00e1hrifum <\/span><\/span>
\n\u2022 Samanbur\u00f0ur \u00e1 lyfhrifum vi\u00f0 skyld efnasamb\u00f6nd<\/span><\/span><\/p>\n

Handb\u00f3k til ranns\u00f3knarstofu<\/span><\/span><\/strong><\/h3>\n

\u25c9\u00a0 <\/span><\/span>Geymsla<\/span><\/span><\/strong> Geymi\u00f0 vi\u00f0 2-8\u00b0C \u00ed upprunalegum lj\u00f3s\u00feolnum umb\u00fa\u00f0um. <\/span><\/span>
\n\u25c9\u00a0 <\/span><\/span>\u00d6ryggi<\/span><\/span><\/strong> Noti\u00f0 alltaf \u00ed st\u00fdr\u00f0u ranns\u00f3knarstofuumhverfi <\/span><\/span>
\n\u25c9\u00a0 <\/span><\/span>Skammtar<\/span><\/span><\/strong> N\u00e1kv\u00e6m greiningarvogunarb\u00fana\u00f0ur sem \u00fearf til frekari undirsk\u00f6mmtunar<\/span><\/span><\/p>\n

Uppl\u00fdsingar um p\u00f6ntun<\/span><\/span><\/strong><\/h3>\n